Clinical practice guideline for management of methamphetamine/ amphetamine user disorder for general practitioners and medical personnel

Abstract

This clinical practice guideline aims to provide direction for the treatment and care of methamphetamine/amphetamine users in healthcare facilities. It emphasizes standardized and quality care within the context of limited human resources, facilities, and equipment. The guideline was developed by systematically reviewing literature and is intended to serve as a preliminary guide for general practitioners and medical personnel in the management of methamphetamine/amphetamine users. The management and care sections include: a flowchart summarizing the overall care for symptoms ranging from mild to severe; the treatment of psychiatric symptoms; the management of agitation; the use of medication for sedation and relief of psychiatric symptoms; guidelines for interviewing history related to methamphetamine/amphetamine use; and guidelines for diagnosis, treatment, and ongoing care during the recovery phase. The guideline considers both Substance Use Disorder (SUD) and Substance-Induced Disorder (SID) concurrently, as these conditions frequently co-occur. Treatment is categorized based on the specific psychiatric symptoms present. Furthermore, it offers recommendations for medication to treat psychiatric symptoms and alleviate other symptoms, considering the fundamental National Essential Drug List available in community hospitals. The guideline also emphasizes psychosocial intervention as a crucial component in the care of methamphetamine/amphetamine users. This clinical practice guideline is therefore suitable for general practice or emergency room settings that require urgent treatment, specifically designed for patient care within the context of resource-limited community hospitals in rural areas. The primary goal is to facilitate easy review and practical application by residents, general practitioners, and multidisciplinary teams in their local service areas.